Dr. Sherbenou is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1665 Aurora CT
1665 Aurora Court Mail Stop F754
Aurora, CO 80045Phone+1 803-213-2731
Summary
- I am a physician scientist at the University of Colorado Anschutz Medical Campus focused on patient care and translational research for multiple myeloma.
Clinical Expertise
- Hematologic oncology, Laboratory research, Plasma cell disorders, Autologous stem cell transplantation, Translational Research, POEMS syndrome, Monoclonal gammopathy of unknown significance, Waldenstrom's macroglobulinemia
Education & Training
- University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2012 - 2014
- University of Utah HealthResidency, Internal Medicine, 2009 - 2012
- Oregon Health and Science University School of MedicineClass of 2009
Certifications & Licensure
- CA State Medical License 2012 - Present
- CO State Medical License 2015 - 2025
- UT State Medical License 2010 - 2014
Awards, Honors, & Recognition
- Translational Research Training in Hematology European Hematology Association/American Society of Hematology, 2018
- Loan Repayment Program National Cancer Institute
- 2016 Young Investigator Award National Comprehensive Cancer Network (NCCN) Foundation
- Join now to see all
Publications & Presentations
PubMed
- 156 citationsCharacterization of Murine JAK2V617F-Positive Myeloproliferative DiseaseThomas Bumm, Collin R. Elsea, Amie S. Corbin, Marc M. Loriaux, Daniel W. Sherbenou
Cancer Research. 2006-12-01 - 26 citationsEmerging Therapeutic Strategies to Overcome Drug Resistance in Multiple MyelomaLorraine N Davis, Daniel W. Sherbenou
Cancers. 2021-04-02 - 2 citationsCD46-ADC Reduces the Engraftment of Multiple Myeloma Patient-Derived Xenografts.Michael J VanWyngarden, Zachary J Walker, Yang Su, Olivia Perez de Acha, Brett M Stevens
Cancers. 2023-11-09
Press Mentions
- American Cancer Society Awards 90 New Research and Career Development Grants Totaling $45 MillionApril 13th, 2023
- First Person – Shelby BearrowsJuly 1st, 2019
- NCCN Foundation Awards Grants to Five Young InvestigatorsApril 1st, 2016
- Join now to see all
Grant Support
- Targeting Cancer Initiating Cells in Multiple MyelomaNational Cancer Institute/National Institutes of Health2018–2023
- A patient-derived xenograft model of multiple myeloma to test anti-CD46 antibody drug conjugate for curative potential.National Comprehensive Cancer Network (NCCN Foundation2016–2018
Committees
- Committee Member, Protocol Review Committee, University of Colorado Cancer Center 2016 - Present
- Interviewer/Committee Member, Hematology/Oncology Fellowship Admissions 2016 - Present
- Co-chair, Cancer Biology Graduate Program Seminar Series 2016 - Present
- Faculty Mentor, Cancer Biology Graduate Program Retreat Organizing Committee 2016 - Present
Research History
- Ex Vivo Drug Sensitivity Screening to Personalize Treatment for Multiple Myeloma2016 - Present
- Targeting Multiple Myeloma with the CD46-Antibody Drug Conjugate2013 - Present
- Screening for Drug Resistance Mutations in Patients with Chronic Myeloid Leukemia on Treatment with Imatinib/Gleevec2003 - 2007
- Characterization of Sodium Channel Isoform Expression in the Peripheral Nervous System1995 - 1997
- Two-Hybrid Screen for SUR2 Interaction Partners in the C.elegans Ras Pathway1994 - 1995
Professional Memberships
- Member
- Member
- Society for Immunotherapy of CancerMember
- International Myeloma SocietyMember
External Links
- Faculty Profilehttps://www.cudoctors.com/Find_A_Doctor/Profile/16907
- Lab Homepagehttp://sherbenoulab.org
- Linked-Inhttps://www.linkedin.com/in/daniel-sherbenou-45109983/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: